Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting

PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex conce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Trauma Emerg Surg
Autors principals: Černý, Vladimir, Maegele, Marc, Agostini, Vanessa, Fries, Dietmar, Leal-Noval, Santiago R., Nardai, Gábor, Nardi, Giuseppe, Östlund, Anders, Schöchl, Herbert
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2021
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7782571/
https://ncbi.nlm.nih.gov/pubmed/33399876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00068-020-01563-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars